Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin.
HoJin ShinSebastian G SchneeweissRobert J GlynnElisabetta PatornoPublished in: Annals of internal medicine (2022)